Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04504188 · ClinicalTrials.gov registry record · NA
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
A NA study of Heart Failure and Cardiomyopathies, sponsored by Zoll Medical Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 4
- Study locations
NCT04504188 is a NA study of Heart Failure and Cardiomyopathies that is actively recruiting participants, run by Zoll Medical Corporation. The registered enrollment target is 300 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT04504188, a NA study of Heart Failure and Cardiomyopathies, is actively recruiting participants, sponsored by Zoll Medical Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this pilot study is to document the percentage achievement in effective HR control (average nighttime HR \< 70 bpm) during WCD use in a cohort of female patients with cardiomyopathy in an outpatient setting using continuous heart rate (HR) trends data from the WCD to optimize BB/ivabradine dosage, as compared to a prior historical control.
Conditions Studied
Interventions
- DEVICE Heart Rate Monitor Enhanced Treatment Optimization
Study Locations (4)
Texas
- Texas Cardiology Associates of Houston - Kingwood
- CardioVoyage - McKinney
Ohio
- TriHealth Hatton Research Institute - Cincinnati
West Virginia
- CAMC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2024-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04504188
The ClinicalTrials.gov registry entry for NCT04504188 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Heart Rate Monitor Enhanced Treatment Optimization is the first listed.
NCT04504188 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Texas, Ohio, West Virginia.
Frequently Asked Questions
What is clinical trial NCT04504188 about?
NCT04504188 is a clinical study titled "Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator". The primary objective of this pilot study is to document the percentage achievement in effective HR control (average nighttime HR \< 70 bpm) during WCD use in a cohort of female patients with cardiomyopathy in an outpatient setting using continuous heart rate (HR) trends data from the WCD to optimiz...
What is the current status of trial NCT04504188?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-03-08. Estimated completion is 2024-12.
What conditions does trial NCT04504188 study?
This clinical trial studies the following conditions: Heart Failure, Cardiomyopathies.
What interventions are being tested in trial NCT04504188?
The interventions under investigation include: Heart Rate Monitor Enhanced Treatment Optimization (DEVICE).
Who is sponsoring clinical trial NCT04504188?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04504188 being conducted?
This trial has 4 study locations across Ohio, Texas, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.